Biological Agents

Julia Greig(Sheffield Teaching Hospitals NHS Foundation Trust), Chris Ellis

Unknown

January 1, 2005

10.1002/9780470755075.ch23

Cited by 2

Related Papers

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

|The Lancet|2017|186

Supporting wellbeing in motor neurone disease for patients, carers, social networks, and health professionals: A scoping review and synthesis

|Palliative & Supportive Care|2017|34

Anakinra in the treatment of protracted paradoxical inflammatory reactions in HIV-associated tuberculosis in the United Kingdom: a report of two cases

|International Journal of STD & AIDS|2020|31

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial

|Trials|2012|27

The use of adjuvant granulocyte-macrophage colony-stimulating factor in HIV-related disseminated atypical mycobacterial infection

|Journal of Infection|2006|21